Table of Contents Table of Contents
Previous Page  126 / 2894 Next Page
Information
Show Menu
Previous Page 126 / 2894 Next Page
Page Background

function in seronegative MG. Neurology 59:1682,

2002.

76. Albuquerque EX,AlkondonM,Pereira EF,et al: Proper-

ties of neuronal nicotinic acetylcholine receptors: Phar-

macologic characterization and modulation of synaptic

function. J Pharmacol Exp Ther 280:1117, 1997.

77. Maelicke A, Coban T, Storch A, et al: Allosteric modu-

lation of

Torpedo

nicotinic acetylcholine receptor ion

channel activity by noncompetitive agonists. J Recep-

tor Signal Transduc Res 17:11, 1997.

78. Creese R, Head SD, Jenkinson DF: The role of the

sodium pump during prolonged end-plate currents in

guinea-pig diaphragm. J Physiol 384:377, 1987.

79. Ibebunjo C,Martyn

JAJ:Thermal

injury induces greater

resistance to d-tubocurarine in local than in distant

muscles in the rat. Anesth Analg 91:1243, 2000.

80. Fischer U, Reinhardt S, Albuquerque EX, Maelicke A:

Expression of functional alpha7 nicotinic acetylcho-

line receptor during mammalian muscle development

and denervation. Eur J Neurosci 11:2856, 1999.

81. Tsuneki H, Salas R, Dani JA: Mouse denervation

increases expression of alpha 7 nicotinic receptor

with unusual pharmacology. J Physiol 547:169, 2003.

82. Lindstrom JM: Nicotinic acetylcholine receptors of

muscles and nerves: Comparison of their structures,

functional roles, and vulnerability to pathology. Ann

N Y Acad Sci 998:41, 2003.

83. Placzek AN, Grassi F, Papke T, et al: A single point

mutation confers properties of the muscle-type

nicotinic acetylcholine receptor to homomeric alpha7

receptors. Mol Pharmacol 66:169, 2004.

84. Hirose M, Kaneki M, Martyn JAJ, et al: Immobiliza-

tion depresses insulin signaling in skeletal muscle.

Am J Physiol 279:E1235, 2000.

85. Sugita H, Kaneki M, Martyn JAJ, et al: Burn injury

impairs insulin-stimulated Akt/PKB activation in

skeletal muscle. Am J Physiol Endocrinol Metab

288:E585, 2005.

86. Hirose M, Kaneki M, Martyn JAJ, et al: Long-term

denervation impairs insulin receptor substrate

(IRS)-1–mediated insulin signaling in skeletal muscle.

Metabolism 50:216, 2001.

87. Gronert GA: Cardiac arrest after succinylcholine:

Mortality greater with rhabdomyolysis than receptor

upregulation. Anesthesiology 94:523, 2001.

88. Lukas RJ, Changeux J-P, Novère NL, et al: Internatio-

nal union of pharmacology. XX. Current status of the

nomenclature for nicotinic acetylcholine receptors

and their subunits. Pharmacol Rev 51:397, 1999.

89. Chiodini F, Charpantier E, Muller D, et al: Blockade

and activation of the human neuronal nicotinic

acetylcholine receptors by atracurium and laudano-

sine. Anesthesiology 94:643, 2001.

90. Vizi ES, Lendvai B: Side effects of nondepolarizing

muscle relaxants: Relationship to their antinicotinic and

antimuscarinic actions. Pharmacol Ther 73:75, 1997.

91. Tsuneki H, Kimura I, Dezaki K, et al: Immunohisto-

chemical localization of neuronal nicotinic receptor

subtypes at the pre- and postjunctional sites in mouse

diaphragm muscle. Neurosci Lett 196:13, 1995.

92. Faria M, Oliveira L, Timoteo MA, et al: Blockade of

neuronal facilitatory nicotinic receptors containing

alpha 3 beta 2 subunits contribute to tetanic fade in

the rat isolated diaphragm. Synapse 49:77, 2003.

93. Martyn J, Durieux ME: Succinylcholine: New insights

into mechanisms of action of an old drug. Anesthe-

siology 104:633, 2006.

94. Eriksson LI: Reduced hypoxic chemosensitivity in

partially paralysed man. A new property of muscle

relaxants? Acta Anaesthesiol Scand 40:520, 1996.

95. Taylor P: Anticholinesterase agents.

In

Bruton LL,

Lazo JS, Parker KL (eds): Goodman & Gilman’s Phar-

macological Basis of Therapeutics,,11th ed.NewYork,

McGraw Hill, 2006, pp 201.

96. de Boer HD, Driessen JJ, Marcus MA, et al: Reversal of

rocuronium-induced (1.2mg/kg) profound neuromus-

cular block by sugammadex: A multicenter, dose-fin-

ding and safety study. Anesthesiology 107:239, 2007.

97. Richtsfeld M, Blobner M, Martyn JAJ: Chronic admi-

nistration of pyridostigmine leads to a myasthenia-

like state with down-regulation of acetylcholine

receptors. Young Investigator Award for abstract

presented at ASCCA at the ASA Annual Meeting of

the American Society of Anesthesiologists, October

2003, San Francisco.

I

126

Fisiología y anestesia